PAPER Akhter R, Sanphui P, Biswas SC
SEARCH RESULTS
329930 RESULTS
PAPER Boopathi S, Kolandaivel P
Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein.
J Mol Model. 2014 Mar;20(3):2109. Epub 2014 Feb 25 PubMed: 24567151PAPER Brosseron F, Krauthausen M, Kummer M, Heneka MT
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer's Disease: a Comparative Overview.
Mol Neurobiol. 2014 Feb 25; PubMed: 24567119PAPER
Alzheimer disease: Wnt signalling-a promising target for AD treatment.
Nat Rev Neurol. 2014 Mar;10(3) Epub 2014 Feb 25 PubMed: 24567002PAPER Skillbäck T, Rosén C, Asztely F, Mattsson N, Blennow K, Zetterberg H
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
JAMA Neurol. 2014 Apr;71(4):476-83. PubMed: 24566866PAPER Sima X, Xu J, Li J, Zhong W, You C
Expression of β-amyloid precursor protein in refractory epilepsy.
Mol Med Rep. 2014 Apr;9(4):1242-8. Epub 2014 Feb 21 PubMed: 24566726PAPER Jang H, Teran Arce F, Ramachandran S, Kagan BL, Lal R, Nussinov R
Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.
Chem Soc Rev. 2014 Feb 24; PubMed: 24566672PAPER Song J, Ahn IS, Kang HS, Myung W, Lee Y, Woo SY, Ku HM, Hwang TY, Carroll BJ, Kim DK
Cognitive subdomain responses to galantamine in Alzheimer's disease.
J Nerv Ment Dis. 2014 Mar;202(3):253-9. PubMed: 24566512PAPER Saravanaraman P, Chinnadurai RK, Boopathy R
Why calcium channel blockers could be an elite choice in the treatment of Alzheimer's disease: a comprehensive review of evidences.
Rev Neurosci. 2014;25(2):231-46. PubMed: 24566363PAPER McAvoy T, Lassman ME, Spellman DS, Ke Z, Howell BJ, Wong O, Zhu L, Tanen M, Struyk A, Laterza OF
Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometry.
Clin Chem. 2014 Apr;60(4):683-9. Epub 2014 Feb 24 PubMed: 24566260PAPER Howe AS, Bani-Fatemi A, De Luca V
The clinical utility of the auditory P300 latency subcomponent event-related potential in preclinical diagnosis of patients with mild cognitive impairment and Alzheimer's disease.
Brain Cogn. 2014 Apr;86:64-74. Epub 2014 Feb 22 PubMed: 24565814PAPER Tang M, Shi S, Guo Y, Xu W, Wang L, Chen Y, Wang Z, Qiao Z
GSK-3/CREB pathway involved in the gx-50's effect on Alzheimer's disease.
Neuropharmacology. 2014 Jun;81:256-66. Epub 2014 Feb 21 PubMed: 24565641PAPER Rosa-Neto P, Hsiung GY, Masellis M, CCDTD4 participants
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.
Alzheimers Res Ther. 2013 Nov 25;5(Suppl 1):S8. PubMed: 24565514PAPER Masellis M, Sherborn K, Neto P, Sadovnick DA, Hsiung GY, Black SE, Prasad S, Williams M, Gauthier S
Early-onset dementias: diagnostic and etiological considerations.
Alzheimers Res Ther. 2013 Jul 31;5(Suppl 1):S7. PubMed: 24565469PAPER Cook C, Rockwood K
Knowledge translation: an overview and recommendations in relation to the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia.
Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S6. PubMed: 24565407Current Filters
No filters selected